Huber Research Resources, Inc.
Secure, small-scale formulation, testing, and storage solutions for researchers and sponsors working with Schedule I psychedelic compounds.
What We Do
Contract Research Services for Psychedelic Drug DevelopmentHuber Research Resources (HRR) is a privately owned, DEA-registered Contract Research Organization (CRO) specializing in the preparation, storage, and support of Schedule I pharmaceutical research.We offer two core service lines: Execution Services, and Development Services.
Who We Serve
Trusted Support for Schedule I ResearchersHRR partners with organizations advancing the future of psychedelic medicine. Whether you're leading an academic study or developing a new investigational drug, we provide the infrastructure and expertise you need to conduct research confidently and compliantly.We work with:
- Academic and institutional researchers
- Psychedelic drug developers
- Clinical trial sponsors
- Other CROs needing secure, U.S. based compound services
Why HRR?
Regulatory Precision, Research IntegrityHRR was founded by professionals with deep roots in both engineering and pharmaceutical sciences. We operate with transparency, security, and compliance at the center of everything we do.Why clients choose HRR:
- U.S.-based, fully DEA Schedule I-compliant facility (licensure in progress)
- Responsive, low-overhead service model
-No fluff — just technical competence and regulatory alignment
-Founder-led with direct accountabilityWe’re not here to compete with Big Pharma. We’re here to support the researchers moving psychedelic science forward.
Execution Services
Secure, Compliant Infrastructure for Psychedelic Compound HandlingHRR provides the operational support necessary for safe and legally compliant Schedule I research. Our execution services ensure your materials are protected, stable, and properly prepared throughout early-stage development.Core capabilities include:
- Secure Schedule I compound storage (DEA-compliant facility)
- Climate-controlled stability and shelf-life testing
- Small-batch preparation and verification for preclinical studies
- Inventory management and sample tracking
- Technical documentation and chain-of-custody supportThese services are ideal for researchers and sponsors who need precision, security, and speed without the overhead of large-scale operations.
Development Services
Custom Formulation and Method Development for Psychedelic CompoundsOur development services support innovation in psychoactive pharmaceutical research. We collaborate closely with clients to create and refine drug formulations and protocols that meet both scientific goals and regulatory requirements.Core capabilities include:
- Lyophilized psilocybin dosage form development
- Analytical method development and documentation
- Formulation optimization and feasibility studies
- Support for IND-enabling activities and preclinical trial prep
- Batch record creation and process scale-up consultationThese offerings are designed for biotech startups, academic labs, and clinical trial sponsors seeking hands-on, compliant R&D support.
Meet the Founder
Dayna Huber, MS | Founder
Dayna Huber is a pharmaceutical scientist, engineer, and U.S. Air Force veteran with a multidisciplinary background in regulatory compliance, process engineering, and psychoactive drug development. She holds a Master of Science in Pharmaceutical Sciences from the University of Wisconsin–Madison, with a focus on psychoactive pharmaceutical investigation.Before launching HRR, Dayna worked in both industrial engineering and cannabinoid research, leading technical projects in GMP environments and managing plant-scale system revamps. She founded Huber Research Resources to bridge the gap between psychedelic innovation and the infrastructure required for safe, compliant development.Driven by a deep commitment to scientific rigor, ethical access, and regulatory transparency, Dayna leads HRR with the belief that high-integrity research environments are the foundation of future psychedelic medicines.
Contact / Consultation Form
Let’s TalkHave a project or question? Reach out below — we typically respond within one business day.